Cargando…
Advances in blood-based protein biomarkers for Alzheimer's disease
Alzheimer's disease (AD) is a neurodegenerative disorder that accounts for the majority of dementia cases. While research over the past decades has made advances into understanding disease pathology, definite AD diagnosis currently relies on confirmation by autopsy. The anticipated dramatic ris...
Autores principales: | Clark, Lorraine Fuhrmann, Kodadek, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706757/ https://www.ncbi.nlm.nih.gov/pubmed/23659521 http://dx.doi.org/10.1186/alzrt172 |
Ejemplares similares
-
Blood‐based biomarkers for Alzheimer's disease
por: Leuzy, Antoine, et al.
Publicado: (2021) -
And then there were two
por: Clark, Lorraine F, et al.
Publicado: (2015) -
Latest advances in cerebrospinal fluid and blood biomarkers of
Alzheimer’s disease
por: Milà-Alomà, Marta, et al.
Publicado: (2019) -
Blood-based molecular biomarkers for Alzheimer’s disease
por: Zetterberg, Henrik, et al.
Publicado: (2019) -
Roadblocks for integration of novel biomarker concepts into clinical routine: the peptoid approach
por: Vanderstichele, Hugo, et al.
Publicado: (2014)